Member Login

Members of the PRCSG can login here for access to the members-only parts of this site.
Print E-mail

PRCSG NewsImage

Announced July 13, 2010: New boxed warning for severe liver injury with Arava (leflunomide).

 

Announced November 2009: ENBREL revised boxed warning released.  

 

Announced 11/20/2009: Press Release: ACTEMRA Improves Signs and Symptoms in Children with Systemic Onset Juvenile Idiopathic Arthritis (sJIA); Impressive Phase III data advances treatment options in sJIA.

 

Announced 10/23/2009: Genentech notifies healthcare professionals about 3rd case of PML with Rituximab treatment.

 

Announced 10/23/2009: FDA releases updated Guidance for Industry: Investigator Responsibilities.  

 

Announced 8/4/2009: Information for Healthcare Professionals: TNF Blockers FDA alert. Amgen and Wyeth response August 7, 2009.

 

Announced 7/14/2009: The PRCSG has issued a response to the FDA Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry.

 

 

 

 

Abstracts Presented at EULAR 2010 
 
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tocilizumab in Patient with Systemic Juvenile Idiopathic Arthritis (SJIA): 12-Week Data from the Phase 3 TENDER Study
 
Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 12-Week Data from the Phase 3 TENDER Trial
 
 
 

 
 

Copyright © 2007 prcsg.org

Joomla Templates by Joomlashack